A new study by Canadian researchers will explore the possibility of reducing medication for arthritis patients whose disease has already been ... Read more
Adalimumab showed better long-term safety and efficacy results compared to infliximab in the treatment of juvenile idiopathic arthritis (JIA)-associated uveitis, or the inflammation ... Read more
Children with juvenile idiopathic arthritis (JIA) may experience impaired vertical growth in the first three years of the disease, according to ... Read more
Abatacept, marketed as Orencia by Bristol-Myers Squibb, was seen to improve the symptoms of polyarticular-course juvenile idiopathic arthritis (pJIA) in a Phase ... Read more
